Role of aryl hydrocarbon receptor-mediated induction of the CYP1 enzymes in environmental toxicity and cancer

DW Nebert, TP Dalton, AB Okey, FJ Gonzalez - Journal of biological …, 2004 - ASBMB
The mammalian CYP1A1, CYP1A2, and CYP1B1 genes (encoding cytochromes P450 1A1,
1A2, and 1B1, respectively) are regulated by the aromatic hydrocarbon receptor (AHR). The …

Involvement of cytochrome P450 enzymes in inflammation and cancer: a review

MC Stipp, A Acco - Cancer chemotherapy and pharmacology, 2021 - Springer
Cytochrome P450 (CYP) enzymes are responsible for the biotransformation of drugs,
xenobiotics, and endogenous substances. This enzymatic activity can be modulated by …

Methylenetetrahydrofolate reductase polymorphisms increase risk of esophageal squamous cell carcinoma in a Chinese population

C Song, D Xing, W Tan, Q Wei, D Lin - Cancer research, 2001 - AACR
Methylenetetrahydrofolate reductase (MTHFR) plays a central role in folate metabolism that
affects DNA methylation and synthesis. Because germ-line mutations at nucleotides 677 …

Pharmacogenetics of the major polymorphic metabolizing enzymes

AK Daly - Fundamental & clinical pharmacology, 2003 - Wiley Online Library
There is increasing information available on the existence of polymorphisms in genes
encoding xenobiotic metabolizing enzymes and the functional significance of many of these …

Cytochrome P450 in cancer susceptibility and treatment

B Mittal, S Tulsyan, S Kumar, RD Mittal… - Advances in clinical …, 2015 - Elsevier
Abstract Cytochrome 450 (CYP450) designates a group of enzymes abundant in smooth
endoplasmic reticulum of hepatocytes and epithelial cells of small intestines. The main …

Glutathione S-Transferase M1 (GSTM1) Polymorphisms and Lung Cancer: A Literature-based Systematic HuGE Review and Meta-Analysis

C Carlsten, GS Sagoo, AJ Frodsham… - American journal of …, 2008 - academic.oup.com
Multiple genes have been studied for potential associations with lung cancer. The gene
most frequently associated with increased risk has been glutathione S-transferase M1 …

Genetic polymorphisms of drug-metabolising enzymes and drug transporters in the chemotherapeutic treatment of cancer

TM Bosch, I Meijerman, JH Beijnen… - Clinical …, 2006 - Springer
There is wide variability in the response of individuals to standard doses of drug therapy.
This is an important problem in clinical practice, where it can lead to therapeutic failures or …

Substantial reduction in risk of lung adenocarcinoma associated with genetic polymorphism in CYP2A13, the most active cytochrome P450 for the metabolic activation …

H Wang, W Tan, B Hao, X Miao, G Zhou, F He, D Lin - Cancer Research, 2003 - AACR
Abstract Cytochrome P450 2A13 (CYP2A13), an enzyme expressed predominantly in the
human respiratory tract, exhibits high efficiency in the metabolic activation of tobacco …

Cytochrome P-450 1A1 gene polymorphisms and risk of breast cancer: a HuGE review

LF Masson, L Sharp, SC Cotton… - American journal of …, 2005 - academic.oup.com
Abstract Cytochrome P-450 (CYP) 1A1 plays a key role in phase I metabolism of polycyclic
aromatic hydrocarbons and in estrogen metabolism. It is expressed predominantly in …

CYP1A1 and CYP1B1 polymorphisms and risk of lung cancer among never smokers: a population-based study

AS Wenzlaff, ML Cote, CH Bock, SJ Land… - …, 2005 - academic.oup.com
The cytochrome P450 (CYP) superfamily of enzymes catalyse one of the first steps in the
metabolism of carcinogens such as polycyclic aromatic hydrocarbons, nitroaromatics and …